Around 80% of skin biopsies come back clear. That is more than 600,000 needless procedures in Australia each year, wasting $400 million AUD. DeepDerm is built to catch that at the point of care.
DeepDerm brings together precision imaging, explainable AI, and a skin diary, so a single consultation extends naturally into the care that follows.
Image.
More signal than the eye can read, across multiple imaging modalities simultaneously.
Interpret.
Specialist-grade interpretation, delivered as a calibrated decision the clinician can trust.
Follow.
Patients capture lesions between visits. DeepDerm flags change to the clinic.
I strongly endorse this initiative. Our unit is committed to supporting it through dermatology expertise and clinical oversight, to advance safe, equitable, and effective skin cancer detection across our region.
Current treatments still seem like black magic. DeepDerm can provide decision support to doctors and a sense of security to patients.
The technology works like a normal camera. It is non-invasive, label-free and works in real time, with the potential to reduce biopsies of non-malignant lesions for every patient, regardless of skin tone.
Noor conceived and initiated this work on early melanoma detection, and her enthusiasm has inspired clinicians and researchers from the Skin Health Institute and Peter MacCallum Cancer Centre to get involved. She is a self-starter, always proactive in seeking out new opportunities.
I strongly endorse this initiative. Our unit is committed to supporting it through dermatology expertise and clinical oversight, to advance safe, equitable, and effective skin cancer detection across our region.
Current treatments still seem like black magic. DeepDerm can provide decision support to doctors and a sense of security to patients.
The technology works like a normal camera. It is non-invasive, label-free and works in real time, with the potential to reduce biopsies of non-malignant lesions for every patient, regardless of skin tone.
Noor conceived and initiated this work on early melanoma detection, and her enthusiasm has inspired clinicians and researchers from the Skin Health Institute and Peter MacCallum Cancer Centre to get involved. She is a self-starter, always proactive in seeking out new opportunities.
In partnership with
Backed by
Exciting news on further funding to be announced soon.
Whether you are a clinician, a research partner, or a health system exploring AI-augmented care, we would like to hear from you.
